Patricia Salber, MD, MBA, of The Doctor Weighs In, said that geographic location is one of the largest disparities impacting healthcare today, for it affects not only the types of plans available to individuals based upon where they live, but it also has an impact on the actual health outcomes of communities across the nation.
Patricia Salber, MD, MBA, of The Doctor Weighs In, said that geographic location is one of the largest disparities impacting healthcare today, for it affects not only the types of plans available to individuals based upon where they live, but it also has an impact on the actual health outcomes of communities across the nation.
Transcript (slightly modified)
How do you see the rising cost of drugs and healthcare affecting disparities?
We already have a huge disparity in healthcare and it’s really a geographic disparity that I don’t see people talking about very much. And the fact is that there’s a real difference between the northern part of the country and the southern part of the country in terms of health insurance, who expanded the Affordable Care Act. It’s not just the southern states that didn’t but a lot of the southern states didn’t expand Medicaid. A lot of them didn’t and even before the expansion of Medicaid, if you look at who is covered in Medicaid in some of the southern states, one of them, I think it's Mississippi, you have to be 29% of the poverty level. So that’s leaving a lot of people out who are uninsured.
But even beyond that, there’s disparities in actual health outcomes. So those of us who do what I do, we talk about the stroke belt, the obesity belt, the heart attack belt, they’re all the same. It’s this southeastern part of the United States. So we have this big disparity now but I think with these new drugs that are coming down the pike, you’re going to see benefit design’s that say, yeah we’ll cover that $80,000 drug but we’re going to put it in the fourth tier with a 25% co-insurance, which means if you got money and these are curative drugs, you’re going to pay for it. But if you don’t have money, you may be getting standard chemotherapy instead.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More